CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-28 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 121,249 | ||
| 2020-02-28 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 121,249 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +25,974 | 186,967 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +25,974 | 212,941 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −25,586 | $17.58 | $450K | 187,355 |
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2020-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise | +25,974 | 81,835 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise | +25,974 | 107,809 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −25,440 | $17.58 | $447K | 82,369 |
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2020-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −25,974 | 29,026 | ||
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise | +25,974 | 514,074 | ||
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise | +25,974 | 540,048 | ||
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −25,586 | $17.58 | $450K | 514,462 |
| 2020-02-25 | Ketchum Steven B Chief Scientific Officer | Grant or award · Restricted Stock Units | +55,000 | 55,000 |
Page 56 of 67 · 1,339 trades